NEXIEN BIOPHARMA, INC. Quarterly Common Stock, Shares, Outstanding from Q2 2017 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Nexien Biopharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2017 to Q4 2024.
  • Nexien Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 70.8M shares, a 8.43% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 70.8M +5.5M +8.43% Dec 31, 2024 10-Q 2025-02-14
Q3 2024 70.5M +5.7M +8.8% Sep 30, 2024 10-Q 2024-11-18
Q2 2024 70.5M +6.45M +10.1% Jun 30, 2024 10-Q 2025-02-14
Q1 2024 67.5M +4.7M +7.49% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 65.3M +3.25M +5.24% Dec 31, 2023 10-Q 2024-02-20
Q3 2023 64.8M +3.5M +5.71% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 64M +3.5M +5.78% Jun 30, 2023 10-K 2024-10-22
Q1 2023 62.8M +2.75M +4.58% Mar 31, 2023 10-Q 2023-05-17
Q4 2022 62M +5.25M +9.25% Dec 31, 2022 10-Q 2023-02-08
Q3 2022 61.3M +5.5M +9.86% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 60.5M +4.75M +8.52% Jun 30, 2022 10-K 2023-09-28
Q1 2022 60M +6.5M +12.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 56.8M +841K +1.5% Dec 31, 2021 10-Q 2022-02-08
Q3 2021 55.8M -9K -0.02% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 55.8M +1.79M +3.31% Jun 30, 2021 10-K 2022-09-28
Q1 2021 53.5M -462K -0.86% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 55.9M +1.95M +3.61% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 55.8M +1.8M +3.33% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 54M +473K +0.88% Jun 30, 2020 10-K 2021-10-12
Q1 2020 54M +268K +0.5% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 54M +268K +0.5% Dec 31, 2019 10-Q 2020-02-12
Q3 2019 54M +9.54M +21.5% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 53.5M +9.06M +20.4% Jun 30, 2019 10-K 2020-09-28
Q1 2019 53.7M +9.96M +22.8% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 53.7M +9.66M +21.9% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 44.4M +19.3M +77% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 44.4M +11.8M +36.3% Jun 30, 2018 10-K 2019-09-30
Q1 2018 43.8M Mar 31, 2018 10-Q 2018-05-15
Q4 2017 44.1M Dec 31, 2017 10-Q 2018-02-14
Q3 2017 25.1M Sep 30, 2017 10-Q 2017-11-03
Q2 2017 32.6M Jun 30, 2017 10-K 2018-09-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.